• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
  • Nowy
Elsevier's 2025 Intravenous Medications

Elsevier's 2025 Intravenous Medications

A Handbook for Nurses and Health Professionals

9780443120404
262,03 zł
222,73 zł Zniżka 39,30 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 222,73 zł
Ilość
Zapowiedź - cena orientacyjna

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
**Selected for Doody’s Core Titles® 2024 with Essential Purchase designation in Pharmacology**

Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elsevier’s Intravenous Medications:: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2025 edition are 16 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
Szczegóły produktu
Elsevier
99704
9780443120404
9780443120404

Opis

Rok wydania
2024
Numer wydania
41
Oprawa
miękka bindowana
Liczba stron
1344
Wymiary (mm)
152 x 229
Waga (g)
450
  • Evolve website information
    General Dilution Charts
    How to Use This Book
    Preface
    Format and Content of Intravenous Medications
    Key to Abbreviations
    Important IV Therapy Facts
    Resources
    Preparation and Administration of Injectable Drugs
    IV Drugs
    Appendix A: Recommendations for the Safe Use and Handling of Cytotoxic Drugs
    Appendix B: FDA Pregnancy Categories
    Appendix C: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE)
    Appendix D: Information for Patients Receiving Immunosuppressive Agents
    Appendix E: Recently Approved Drugs
    Index
Komentarze (0)